Item 8.01. Other Events.

On November 1, 2022, Edwards Lifesciences Corporation, a Delaware corporation, issued a press release announcing its entry into an accelerated share repurchase agreement. A copy of the press release is filed as Exhibit 99.1, and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits



99.1      Press release, issued on November 1, 2022, announcing Accelerated Share
        Repurchase Agreement.

104     Cover Page Interactive Data File (embedded within the inline XBRL
        document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses